pnu100766

Linezolid (PNU-100766), the first of the oxazolidinone class, is a synthetic antibiotic used for the therapy of infections resulted from multi-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and streptococcus. The drug takes effect as the inhibitor of the initiation of bacterial protein synthesis.

(R)-Linezolid, an impurity of Linezolid, inhibits the initiation of bacterial protein synthesis.

Linezolid D3, a deuterium-labeled version of Linezolid, is a synthetic antibiotic designed to halt the initiation of bacterial protein synthesis.

PNU-100766-d8 is a deuterium-labeled form of Linezolid. Linezolid (PNU-100766) is the first member of the oxazolidinone class of synthetic antibiotics, functioning by inhibiting the initiation of bacterial protein synthesis, thereby exhibiting anti-infective properties.